« Previous
Next »
European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 146, Issue 2
, Pages 165-168
, October 2009
Assessment of the female fetal DNA concentration in the plasma of the pregnant women as preeclampsia indicator—Preliminary report
References
- . Quantification of fetal nucleated cells in maternal blood of pregnant women with a male trisomy 21 fetus using molecular cytogenetic techniques. Prenat Diagn. 2006;26:145–150
- Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62:768–775
- . Fetal DNA analyzed in plasma from a mothers three consecutive pregnancies to detect paternally inherited aneuploidy. Clin Chem. 2001;47:937–939
- . Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem. 2000;46:1301–1309
- . Sex determining region Y levels in maternal plasma: evaluation in abnormal pregnancy. J Obstet Gynecol Res. 2004;30:148–154
- . Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet. 1999;64:232–234
- . Fetal cells and cell-free fetal DNA in maternal blood: new insights into preeclmpsia. Hum Reprod Update. 2002;8:501–508
- . Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation?. Placenta. 2005;26:515–526
- . Cell-free DNA and RNA in plasma as new tools for molecular diagnostics. Expert Rev Mol Diagn. 2003;3:785–797
- Fetal RhD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol. 2002;119:255–260
- Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma. Fetal Diagn Ther. 2005;20:275–280
- Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction. Transfus Apheresis Sci. 2002;27:217–223
- . Noninvasise prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem. 2002;48:778–780
- . Improved prenatal detection of a fetal point mutation for achondroplasia by use of size-fractionated circulatory DNA in maternal plasma—case report. Prenat Diagn. 2004;24:896–898
- Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implication for first and second trimester non-invasive prenatal diagnosis. Hum Reprod Update. 2002;8:493–500
- Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol. 2004;190:707–713
- . The correlation between clinical characteristics of preeclampsia and the concentration of fetal DNA in maternal circulation. Eur J Obstet Gynecol. 2008;139:256–260
- Quantitative abnormalities of fetal DNA in maternal serum in pre-eclampsia. Clin Chem. 1999;45:184–188
- . Haemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal plasma and serum. Clin Chem. 2002;48:650–653
- . Noninvasive determination of fetal RhD status by examination of cell-free DNA in maternal plasma. Transfusion. 2005;45:1473–1480
- Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real time quantitative polymerase chain reaction. Blood. 2002;99:4618–4625
- Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. Ann NY Acad Sci. 2001;945:132–137
- Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasma. Obstet Gynecol. 2000;96:991–996
- Elevation of both maternal and fetal extracellular circulating deoxyribonucleic amid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol. 2001;184:414–419
PII: S0301-2115(09)00420-5
doi: 10.1016/j.ejogrb.2009.06.016
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 146, Issue 2
, Pages 165-168
, October 2009
